Literature DB >> 16371366

The tumor suppressor PTEN is necessary for human Sprouty 2-mediated inhibition of cell proliferation.

Francis Edwin1, Rakesh Singh, Raelene Endersby, Suzanne J Baker, Tarun B Patel.   

Abstract

Sprouty family proteins are novel regulators of growth factor actions. Human Sprouty 2 (hSPRY2) inhibits the proliferation of a number of different cell types. However, the mechanisms involved in the anti-proliferative actions of hSPRY2 remain to be elucidated. Here we have demonstrated that hSPRY2 increases the amount of the tumor suppressor phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and decreases its phosphorylation. The resultant increase in PTEN activity is reflected in decreased activation of Akt by epidermal growth factor and serum. Consistent with increased PTEN activity, in hSPRY2-expressing cells, the progression of cells from the G1 to S phase is decreased. By using PTEN null primary mouse embryonic fibroblasts and their isogenic controls as well as small interfering RNA against PTEN, we demonstrated that PTEN is necessary for hSPRY2 to inhibit Akt activation by epidermal growth factor as well as cell proliferation. Overall, we concluded that hSPRY2 mediates its anti-proliferative actions by altering PTEN content and activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16371366     DOI: 10.1074/jbc.M508300200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Bimodal expression of Sprouty2 during the cell cycle is mediated by phase-specific Ras/MAPK and c-Cbl activities.

Authors:  Christoph-Erik Mayer; Barbara Haigl; Florian Jantscher; Gerald Siegwart; Michael Grusch; Walter Berger; Hedwig Sutterlüty
Journal:  Cell Mol Life Sci       Date:  2010-05-12       Impact factor: 9.261

2.  CtBP1 interacts with Ikaros and modulates pituitary tumor cell survival and response to hypoxia.

Authors:  Katie Dorman; Zhongyi Shen; Caimei Yang; Shereen Ezzat; Sylvia L Asa
Journal:  Mol Endocrinol       Date:  2012-02-02

3.  A2B adenosine receptors protect against sepsis-induced mortality by dampening excessive inflammation.

Authors:  Balázs Csóka; Zoltán H Németh; Peter Rosenberger; Holger K Eltzschig; Zoltán Spolarics; Pál Pacher; Zsolt Selmeczy; Balázs Koscsó; Leonóra Himer; E Sylvester Vizi; Michael R Blackburn; Edwin A Deitch; György Haskó
Journal:  J Immunol       Date:  2010-05-26       Impact factor: 5.422

4.  Regulation of cellular levels of Sprouty2 protein by prolyl hydroxylase domain and von Hippel-Lindau proteins.

Authors:  Kimberly Anderson; Kyle A Nordquist; Xianlong Gao; Kristin C Hicks; Bo Zhai; Steven P Gygi; Tarun B Patel
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

5.  Short interfering RNA-induced gene silencing is transmitted between cells from the mammalian central nervous system.

Authors:  Tian-Yong Zhao; Shi-Ping Zou; Yelena V Alimova; Guoying Wang; Kurt F Hauser; M Said Ghandour; Pamela E Knapp
Journal:  J Neurochem       Date:  2006-09       Impact factor: 5.372

6.  PTEN in liver diseases and cancer.

Authors:  Marion Peyrou; Lucie Bourgoin; Michelangelo Foti
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

Review 7.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

8.  HECT domain-containing E3 ubiquitin ligase Nedd4 interacts with and ubiquitinates Sprouty2.

Authors:  Francis Edwin; Kimberly Anderson; Tarun B Patel
Journal:  J Biol Chem       Date:  2009-10-28       Impact factor: 5.157

9.  Sprouty4 interferes with cell proliferation and migration of breast cancer-derived cell lines.

Authors:  Vanita Vanas; Elsa Mühlbacher; Rosana Kral; Hedwig Sutterlüty-Fall
Journal:  Tumour Biol       Date:  2014-01-09

10.  Down-regulation of microRNA-21 is involved in the propofol-induced neurotoxicity observed in human stem cell-derived neurons.

Authors:  Danielle M Twaroski; Yasheng Yan; Jessica M Olson; Zeljko J Bosnjak; Xiaowen Bai
Journal:  Anesthesiology       Date:  2014-10       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.